Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary BioScrip Provides Update on Annual Form 10-K Filing Status
DENVER --(BUSINESS WIRE)--Mar. 15, 2018-- BioScrip, Inc. (NASDAQ: BIOS) (" BioScrip " or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that it will be filing a Form 12b-25 with the U.S.
Toggle Summary BioScrip Reports Fourth Quarter and Full Year 2017 Financial Results
DENVER --(BUSINESS WIRE)--Mar. 8, 2018-- BioScrip, Inc. (NASDAQ: BIOS) (" BioScrip " or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its preliminary 2017 financial results and provided financial guidance for 2018, subject
Toggle Summary BioScrip Schedules Release of Fourth Quarter and Full Year 2017 Financial Results and Conference Call
DENVER --(BUSINESS WIRE)--Feb. 22, 2018-- BioScrip, Inc. (NASDAQ: BIOS) (" BioScrip " or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will issue its financial results press release for the fourth quarter
Toggle Summary BioScrip Announces U.S. Congress Passage of Medicare Home Infusion Transition Benefit, Effective 2019
DENVER --(BUSINESS WIRE)--Feb. 9, 2018-- BioScrip, Inc. (NASDAQ:BIOS) (" BioScrip " or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the U.S. Congress today passed the Medicare Home Infusion Therapy Access Act of 2017
Toggle Summary BioScrip Announces Availability of HEMLIBRA® for Hemophilia Patients
DENVER , Jan. 08, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that it can now dispense and administer HEMLIBRA® (emicizumab-kxwh), a U.S.
Toggle Summary BioScrip to Host Meetings at the Mizuho Investor Conference
DENVER , Nov. 30, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen Deitsch ,
Toggle Summary BioScrip Announces Additions to Senior Leadership Team
Appoints Harriet Booker as Senior Vice President, Chief Operating Officer and Danny R. Claycomb as Senior Vice President, Revenue Cycle Management DENVER , Nov. 28, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of
Toggle Summary BioScrip to Present at Bank of America Merrill Lynch 2017 Leveraged Finance Conference
DENVER , Nov. 16, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen Deitsch ,
Toggle Summary BioScrip to Host Meetings at the 8th Annual Craig-Hallum Alpha Select Conference
DENVER , Nov. 09, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Stephen Deitsch , Senior Vice President, Chief Financial Officer and Treasurer and
Toggle Summary BioScrip Reports Third Quarter 2017 Financial Results
– Net revenue of $198.7 million , including core product mix of 75.0%, compared to 65.8% in the prior year – Net revenue and adjusted EBITDA reduced $10.0 million and $3.0 million , respectively, due to sales disruption from Hurricane Irma, Hurricane Harvey, and completion of the UnitedHealthcare